Global HIV rates drop 20 but challenges persist in ending AIDS by 2030 Explore breakthroughs like lenacapavir prevention ...

Once inside the body, HIV persists because of its remarkable ability to hide within healthy CD4 T cells, where it can lie ...

A new Lancet study reports notable progress in combating HIV, with a 20% drop in new infections and a 40% during the 2010s.

Gilead and Aelix first teamed up in 2018 for a clinical research collaboration agreement to investigate the vaccine.

The number of new HIV infections and deaths has fallen across the world, marking significant progress in the fight against ...

Philanthropist Bill Gates, the founder and co-chair of the Bill and Melinda Gates Foundation says more lives can be saved ...

The latest World Health Organization’s Global Tuberculosis Report released in November 2024 painted a sobering picture; ...

President-elect Trump’s decision to nominate Robert F. Kennedy Jr. for Health and Human Services (HHS) secretary will put ...

While Kennedy’s vaccine skepticism has received more attention ... Kennedy’s suspicion over whether HIV causes AIDS — he’s ...

These new results are marking significant progress in the fight against the disease, but HIV remains far from being stamped ...

Despite progress, Ilori noted significant challenges in preventing mother-to-child transmission (PMTCT), with current ...